News & Insights
Covid-19 : la startup Aqemia sur les rangs pour trouver un médicament
La startup Aqemia, spécialisée dans la recherche de médicaments, adopte une approche différenciante en combinant intelligence artificielle et physique théorique. Un avantage repéré par le Français Sanofi, avec qui elle coopère afin de mettre au point un traitement contre le Covid-19.
Maximilien Levesque ( Aqemia) : La start-up Aqemia reçoit le soutien de Sanofi pour sa recherche de médicaments contre le coronavirus
Maximilien Levesque (CEO and co-founder of Aqemia) discusses Aqemia's partnership with Sanofi to research treatments for COVID-19 on the show Tech&CO (BFM Business).
Press Release - Aqemia receives support and funding from Sanofi to apply its disruptive technology against COVID-19
Aqemia announces an agreement with the pharmaceutical company Sanofi to contribute to the discovery of effective treatments for COVID-19. As part of this agreement, Aqemia will apply its generative AI combined with its disruptive proprietary algorithms for affinity calculation between therapeutic targets and drug candidates.
Aqemia : la rencontre entre un chercheur et une ingénieure pour développer une startup deeptech
La Nouvelle République publishes a portrait of Emmanuelle Martiano (COO and co-founder of Aqemia) and describes how she founded Aqemia with Maximilien Levesque, former researcher at École normale supérieure.
Hiring now: These 10 Paris-based tech startups are currently hiring, despite Covid-19 slump
Aqemia is featured in this list of 10 Paris-based tech startups currently hiring, despite Covid-19 slump
Boston Consulting Group's Newsletter: BÂTISSEUR D'AVENIR - Emmanuelle Martiano cherche des médicaments « in silico »
Emmanuelle Martiano (COO and co-founder of Aqemia) is featured in the BCG’s newsletter, in the section “Bâtisseur d’avenir” as an Alumni who became an entrepreneur with the creation of Aqemia, with the aim of disrupting drug discovery.
